Pharmaceutical | Tokio X'press - Part 31

Randomized Double-Blinded Clinical Trial at Sheba Medical Center: Ivermectin Materially Reduces COVID-19

Thursday February 18th, 2021By Tokio X'press flu, , , , , Pharmaceutical

Osaka Univ: Making eye conjunctival cells with iPS: Expectations for drug discovery of dry eye

Monday February 15th, 2021By Tokio X'press , , , , , IPS, Medical science, Pharmaceutical

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19

Friday February 12th, 2021By Tokio X'press flu, , , , , , , Drugs, Pharmaceutical

Iwate University: Contribution of’Cacerpillar fungus’ substance: dementia and Alzheimer’s disease

Tuesday February 9th, 2021By Tokio X'press Alzheimer, , , , , , Pharmaceutical

First EU Nation To Approve Ivermectin For Covid-19

Wednesday February 3rd, 2021By Tokio X'press flu, , , Pharmaceutical

1 … 30 31 32 … 111